PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma
Clinical trial NCT00049530 · COMPLETED
Trial details
- NCT number
- NCT00049530
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-13
- Primary completion
- 2012-08-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.